Insiders bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 13:24:46 23/01/2026 GMT			5-day change	1st Jan Change
103.00 ^EUR	-1.53%		-1.53%	-6.62%

01-22	Interparfums, Michelin, Société Générale, Ubisoft... Stocks to Watch Today in Paris
01-22	BioMérieux Acquires Remaining 90% Stake in Accellix

Insiders

30/06/24	Aurobac Therapeutics, founded by Boehringer Ingelheim, bioMerieux and Evotec, Names Scientific Advisory Board	CI
16/01/24	BioMérieux appoints two new members to its Executive Committee
28/06/23	BioMérieux: new Director of Clinical Operations
28/02/18	BioMérieux S.A Recommends Dividend, Payable on May 17, 2018, Announces Executive Changes	CI
15/12/17	BioMérieux Announces Management Changes	CI
02/09/16	BioMérieux S.A. Acknowledges the Appointment of Michel Baguenault as Secretary General	CI
28/05/14	BioMérieux Announces Board Changes	CI
15/04/14	Alexandre Mérieux Assumes Role of bioMérieux's Chief Executive Officer and Head of Its Management Committee	CI
05/02/14	BioMérieux SA Appoints Claire Giraut as Corporate Vice President and CFO	CI
18/07/13	BioMérieux SA Announces Management Changes	CI
21/05/13	BioMérieux SA Appoints of Nicolas Cartier as Corporate Vice President	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Biomérieux Q3 earnings miss prompts softer 2025 guidance

Biomérieux Q3 earnings miss prompts softer 2025 guidance

November 04, 2025 at 07:51 pm

As early as today, start finding the best investment opportunities!